Humacyte GAAP EPS of -$0.13 in-line, revenue of $0.47M misses by $0.88M
at seekingalpha.com (Fri, 27-Mar 8:30 AM)
Options Volatility and Implied Earnings Moves Today, March 27, 2026
at www.tipranks.com (Fri, 27-Mar 7:05 AM)
Here are the major earnings before the open Friday
at seekingalpha.com (Thu, 26-Mar 6:00 PM)
Humacyte Q4 2025 Earnings Preview
at seekingalpha.com (Thu, 26-Mar 2:17 PM)
Humacyte's Upcoming March 2026 Update Puts Focus on Symvess Progress and FDA Momentum
Market Chameleon (Mon, 23-Mar 11:46 AM)
Humacyte Secures DoD Funding for FDA-Approved Bioengineered Blood Vessel—Breakthrough in Combat Care
Market Chameleon (Mon, 9-Feb 11:06 AM)
